[Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
Choline-positive neuroprotectors citicoline and choline alfoscerate decreased blood concentration of protein S100 in clinical trial on 52 patients in the first days after acute ischemic stroke. Neuroprotective therapy has also produced stabilization of blood-brain barrier.
O E
OE
Vaizova
N A
NA
Zautner
V M
VM
Alifirova
A I
AI
Vengerovskiĭ
D015415:Biomarkers / Q000097:blood; D001812:Blood-Brain Barrier / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy*; D003566:Cytidine Diphosphate Choline / Q000627:therapeutic use*; D005997:Glycerylphosphorylcholine / Q000627:therapeutic use*; D006801:Humans; D018697:Nootropic Agents / Q000627:therapeutic use*; D010751:Phosphopyruvate Hydratase / Q000097:blood; D009418:S100 Proteins / Q000097:blood*; D020521:Stroke / Q000188:drug therapy*
D015415:Biomarkers; D018697:Nootropic Agents; D009418:S100 Proteins; D003566:Cytidine Diphosphate Choline; D005997:Glycerylphosphorylcholine; D010751:Phosphopyruvate Hydratase